Article

Proposing New Potential Candidates to Inhibit EGFR via Machine Learning Algorithm

2023-04-18

Abstract excerpt

One of the main issues in solid tumours is progressive mutation in epidermal growth factor receptors (EGFR) gene, which activates signalling pathways that create new blood vessels. In this study, it was attempted to find new a therapeutic candidate to inhibit EGFR. One of the cost-effective alternative methods to find new inhibitors has been the repositioning approach of existing drugs. The critical point of compu...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 4b9632f7-d7b7-51a1-b025-3806b0c402d5
DOI: 10.21203/rs.3.rs-2811853/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Proposing New Potential Candidates to Inhibit EGFR via Machine Learning AlgorithmDOI 10.21203/rs.3.rs-2811853/v1Read

Investigating mutation-specific biological activities of small molecules using quantitative structure-activity relationship for epidermal growth factor receptor in cancer.Semantic proximity Read

Computational screening, ensemble docking and pharmacophore analysis of potential gefitinib analogues against epidermal growth factor receptor.Semantic proximity Read

Covalent EGFR Inhibitors: Binding Mechanisms, Synthetic Approaches, and Clinical Profiles.Semantic proximity Read

QSAR-based models for designing quinazoline/imidazothiazoles/pyrazolopyrimidines based inhibitors against wild and mutant EGFR.Semantic proximity Read

Uncovering the Structural and Binding Insights of Dual Inhibitors Simultaneously Targeting Two Distinct Sites on EGFR Kinase.Semantic proximity Read

Novel quinazoline-based EGFR kinase inhibitors: A review focussing on SAR and molecular docking studies (2015-2019).Semantic proximity Read

Computational Insights into the Potential of Withaferin-A, Withanone and Caffeic Acid Phenethyl Ester for Treatment of Aberrant-EGFR Driven Lung Cancers.Semantic proximity Read

Clustering based drug-drug interaction networks for possible repositioning of drugs against EGFR mutations: Clustering based DDI networks for EGFR mutations.Semantic proximity Read

Tyrosine kinase inhibitors - small molecular weight compounds inhibiting EGFR.Semantic proximity Read

Towards identification of novel inhibitors of EGFR mutants through in-silico approach.Semantic proximity Read

Development of triple mutant T790M/C797S allosteric EGFR inhibitors: a computational approach.Semantic proximity Read

Exploring acenocoumarol and silodosin as allosteric EGFR inhibitors for the treatment of non-small cell lung cancerSemantic proximity Read